Atractylenolide I
Atractylenolide-I exhibits anti-inflammatory properties by suppressing TNF-α and IL-6 production, ameliorating sepsis-related organ dysfunction. It also enhances paclitaxel sensitivity in MyD88 (+) cancer cells via inhibition of the TLR4/MyD88 pathway, making it a compound of interest for inflammation and oncology research in both cellular and animal models.
Product Specifications
CAS Number
73069-13-3
Product Name Alternative
TLR, Toll-like Receptor (TLR), TNF-α, STAT, Atractylenolide I, JAK, Janus kinase, inhibit, Inhibitor, ILReceptor, IL-6, IL Receptor
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation, Signal Transduction, Stem Cell & Developmental Biology
Purity
97.55% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.00 mg/mL (8.68 mM) ; DMSO:55.00 mg/mL (238.82 mM)
Smiles
CC1=C2C[C@H]3C (=C) CCC[C@]3 (C) C=C2OC1=O
Molecular Formula
C15H18O2
Molecular Weight
230.30
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Papilloma Virus, Human, Type 18, E6 (hPV, Human Papillomavirus Type 18 E6, E6, Early Protein E6, HpV18gp1, Protein E6) (PE)
Papilloma Virus, Human, Type 18, E6 (hPV, Human Papillomavirus Type 18 E6, E6, Early Protein E6, HpV18gp1, Protein E6) (PE)
